Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Austin L. Chiang, M.D., M.P.H. Joins Medtronic as Chief Medical Officer for Gastrointestinal business

10/21/2021 | 09:00am EST

Medtronic plc announced Austin L. Chiang, M.D., M.P.H., assistant professor of medicine at Sidney Kimmel Medical College, chief medical social media officer of Jefferson Health and director of the Endoscopic Bariatric Program at Thomas Jefferson University Hospital, has joined Medtronic as Chief Medical Officer (CMO) of the Gastrointestinal (GI) business at Medtronic. In this role, Dr. Chiang will provide medical expertise and strategic guidance on evidence development, clinical communications and publications, and training and support needs. Additionally, he will provide oversight to ensure patient safety throughout product lifecycle, including the product development processes, risk management, clinical trials, and safety surveillance. Dr. Chiang is one of the few triple board-certified advanced endoscopy-trained physicians in the world. His certifications include Internal Medicine and Gastroenterology by the American Board of Internal Medicine, and in Obesity Medicine by the American Board of Obesity Medicine. A nationally recognized gastroenterologist and advanced endoscopist, Dr. Chiang is passionate about empowering patients with accurate medical information online. He serves on the board of the Association for Bariatric Endoscopy (ABE) and is a committee member for the American College of Gastroenterology (ACG) and the American Society for Gastrointestinal Endoscopy (ASGE). He is also founding president of the Association for Healthcare Social Media (AHSM). Dr. Chiang was named Healio Gastroenterology's Disruptive Innovator of the Year in 2018 and was a Philadelphia Inquirer Influencer of Healthcare Rookie of the Year in 2019. This year, Dr. Chiang was a nominee for the GLAAD Media TikTok Advocate of the Year award. Dr. Chiang completed his undergraduate degree in Biology at Duke University, and he earned his Medical Doctorate from Columbia University before completing his internal medicine residency at New York Presbyterian Hospital (Columbia University). He completed his gastroenterology and bariatric endoscopy fellowships at Brigham and Women's Hospital/Harvard Medical School and advanced endoscopy fellowship at Thomas Jefferson University Hospital. He is also a graduate of the Harvard T.H. Chan School of Public Health where he earned his master's degree in Public Health.


ę S&P Capital IQ 2021
All news about MEDTRONIC PLC
12/07Medtronic Hugo™ robotic-assisted surgery system receives Health Canada licence, f..
AQ
12/02MEDTRONIC PLC Management's Discussion and Analysis of Financial Condition and Results ..
AQ
12/01Cloud DX selected by Medtronic for national collaboration
AQ
11/30Medtronic receives Health Canada licence for GI Genius™ intelligent endoscopy mod..
AQ
11/28Vincent Medical Strikes Product Distribution Deal with NYSE-listed Medtronic; Shares Ra..
MT
11/24JPMorgan Adjusts Medtronic's Price Target to $130 from $148, Keeps Overweight Rating
MT
11/24Bernstein Adjusts Medtronic's Price Target to $143 from $148, Keeps Outperform Rating
MT
11/24Raymond James Adjusts Medtronic's Price Target to $127 from $142, Keeps Outperform Rati..
MT
11/24Stifel Adjusts Medtronic's Price Target to $140 from $145, Keeps Buy Rating
MT
11/24Truist Securities Adjusts Medtronic's Price Target to $142 from $148, Keeps Buy Rating
MT
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 396 M - -
Net income 2022 5 378 M - -
Net Debt 2022 22 296 M - -
P/E ratio 2022 28,8x
Yield 2022 2,24%
Capitalization 151 B 151 B -
EV / Sales 2022 5,35x
EV / Sales 2023 4,94x
Nbr of Employees 90 000
Free-Float 99,8%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 112,27 $
Average target price 141,32 $
Spread / Average Target 25,9%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC-4.16%150 954
ABBOTT LABORATORIES20.94%234 157
BECTON, DICKINSON AND COMPANY0.06%71 108
HOYA CORPORATION25.65%58 237
DEXCOM, INC.51.03%54 121
ALIGN TECHNOLOGY, INC.24.77%52 573